Kara Long Roche, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kara Long Roche, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:15 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06312124 · A Study of Opportunistic Salpingectomy to Prevent Ovarian CancerMemorial Sloan Kettering Cancer Center · recruiting · Surgery · principal investigator
- N/ANCT05429970 · A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)Memorial Sloan Kettering Cancer Center · recruiting · Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer · principal investigator
- N/ANCT02928549 · Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative StudyMemorial Sloan Kettering Cancer Center · completed · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.